CD8A and AIDS: Considering that human HIV non progressors preferentially maintain highly functional HIV-specific CD8 T cells45, the NYVAC-C Δ3 vaccinia vector in combination with α4β1 integrin inhibitor might result in a promising approach for HIV prophylaxis and AIDS treatment.